Skip to main content

Table 2 Antiretroviral treatment used in ninety-five HIV-1-infected patients

From: Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients

Antiretroviral drugs

Number of patients (%)

TDF

75 (78.9)

ABC

12 (12.6)

3TC

12 (12.6)

FTC

76 (80)

NVP

12 (12.6)

EFV

36 (37.8)

LPV/RTV

5 (5.2)

ATV/RTV

13 (13.6)

ATV

4 (4.2)

DRV/RTV

16 (16.8)

RAL

10 (10.5)

MVC

2 (10.5)

  1. TDF, tenofovir; ABC, abacavir; 3TC, lamivudine; FTC, emtricitabine; NVP, nevirapine; EFV, efavirenz; LPV/RTV, lopinavir/ritonavir; ATV/RTV, atazanvir/ritonavir; DRV/RTV, darunavir/ritonavir; RAL, raltegravir; MVC, maraviroc. All data are expressed as number (%) of patients.